What’s next in immunology & inflammation R&D: The trends to watch

Beyond Biotech - the podcast from Labiotech

Content provided by Labiotech. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Labiotech or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

2M ago 51:25

MP3•Episode home

Immunology and inflammation are hot topics in biotech and biopharma, and innovations are emerging that can change the game for patients suffering from autoimmune, gastrointestinal, and metabolic disease. For top pharma companies, identifying these innovations early is essential and, for university labs, spinouts and startups, getting their science in front of the right industry partners is key. So how does science meet industry, and how can top pharma and venture investors find the next blockbuster?

This week I sat down with Joseph Ferner of Inpart, the author of a new R&D Trends Report on Immunology and Inflammation. He explained the shape of the research landscape, the areas that are generating the most interest amongst industry and investors, and the ways in which digital platforms are helping innovative scientists connect with those who have the experience and finance to bring their technologies and therapies to market.

02:18 The 2025 Immunology and Inflammation R&D Trends Report

08:30 Priorities and challenges in immunology and inflammation research

10:18 The impact of immune system complexity on drug development

13:12 The challenge of clinical heterogeneity

15:33 The role of organoids in immunology and inflammation R&D

17:10 Comparing organoid models to animal models

19:51 The R&D landscape in 2025

22:40 Popular modalities in immunology and inflammation research

24:45 The top innovations in the 2025 R&D Trends Report

28:56 How to score and rank innovations in a rapidly evolving market

33:22 Engagement trends between researchers and industry partners

37:09 Why companies decline to engage with academic researchers

43:36 The Inpart Connect platform and how it works

48:49 Looking forward to the next R&D Trends Report

Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!

Stay updated by subscribing to our newsletter

To dive deeper into the topic:

Why is the immunology and inflammation market suddenly attracting a wave of investment?

Chapters

1. What’s next in immunology & inflammation R&D: The trends to watch (00:00:00)

2. The 2025 Immunology and Inflammation R&D Trends Report (00:02:18)

3. Priorities and challenges in immunology and inflammation research (00:08:30)

4. The impact of immune system complexity on drug development (00:10:18)

5. The challenge of clinical heterogeneity (00:13:12)

6. The role of organoids in immunology and inflammation R&D (00:15:33)

7. Comparing organoid models to animal models (00:17:10)

8. The R&D landscape in 2025 (00:19:51)

9. Popular modalities in immunology and inflammation research (00:22:40)

10. The top innovations in the 2025 R&D Trends Report (00:24:45)

11. How to score and rank innovations in a rapidly evolving market (00:28:56)

12. Engagement trends between researchers and industry partners (00:33:22)

13. Why companies decline to engage with academic researchers (00:37:09)

14. The Inpart Connect platform and how it works (00:43:36)

15. Looking forward to the next R&D Trends Report (00:48:49)

172 episodes

#News #Tech News #Labiotech